|
Quotes & Info
|
| PBYI > SEC Filings for PBYI > Form 8-K on 18-Jun-2012 | All Recent SEC Filings |
18-Jun-2012
Submission of Matters to a Vote of Security Holders
(a) The 2012 Annual Meeting of Stockholders (the "2012 Annual Meeting") of Puma Biotechnology, Inc. (the "Company") was held at 1:00 p.m. Pacific Daylight Time on June 13, 2012, at the Luxe Sunset Boulevard Hotel in Los Angeles, California.
(b) At the 2012 Annual Meeting, the stockholders of the Company:
Proposal 1: Elected the three nominated directors identified below, each to serve
and to hold office for a one-year term until the close of the Company's
next annual meeting of stockholders in 2013, or until a successor has
been duly elected and qualified.
Broker
Nominee For Withheld Abstain Non-Votes
Alan H. Auerbach 10,905,657 2,333,333 0 0
Thomas R. Malley 11,572,323 1,666,667 0 0
Jay M. Moyes 13,238,990 0 0 0
|
Proposal 2: Approved, on an advisory basis, the compensation of the Company's named executive officers.
Broker
For Against Abstain Non-Votes
10,900,657 2,338,333 0 0
Proposal 3: Approved, on an advisory basis, a period of three years as the frequency
of future advisory votes on the compensation of the Company's named
executive officers.
Broker
Three Years Two Years One Year Abstain Non-Votes
7,826,838 13,470 5,398,682 0 0
Proposal 4: Ratified the selection of PKF Certified Accountants, a Professional
Corporation, as the Company's independent registered accounting firm for
the fiscal year ending December 31, 2012.
Broker
For Against Abstain Non-Votes
13,233,990 0 5,000 0
|
(c) Not applicable.
(d) Following the 2012 Annual Meeting, based on the stockholders' approval of three years as the frequency of future advisory votes on the compensation of the Company's named executive officers, the Company's board of directors determined to hold future advisory votes on the compensation of the Company's named executive officers every three years.
|
|